| Literature DB >> 15642916 |
E Masliah1, L Hansen, A Adame, L Crews, F Bard, C Lee, P Seubert, D Games, L Kirby, D Schenk.
Abstract
The authors report a patient with Alzheimer disease (AD) without encephalitis who was immunized with AN-1792 (an adjuvanted formulation of Abeta-42). There were no amyloid plaques in the frontal cortex and abundant Abeta-immunoreactive macrophages, but tangles and amyloid angiopathy were present. The white matter appeared normal and minimal lymphocytic infiltration in the leptomeninges was observed. This case illustrates the effects of an Abeta-based immunization on AD pathogenesis in the absence of overt meningoencephalitis and leukoencephalopathy.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15642916 DOI: 10.1212/01.WNL.0000148590.39911.DF
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910